Vigil Neuroscience, Inc., a Delaware corporation, has announced an update regarding its merger with Sanofi, a French société anonyme. As per the Agreement and Plan of Merger, Sanofi's wholly-owned subsidiary, Vesper Acquisition Sub Inc., will merge with Vigil, with Vigil continuing as a wholly-owned subsidiary of Sanofi. The company filed a definitive proxy statement with the SEC concerning the merger on June 30, 2025. Additionally, Vigil has voluntarily provided supplemental disclosures to address certain litigation matters related to the merger. No new agreements have been made with Parent for the post-merger employment of Vigil's executive officers as of July 28, 2025.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Vigil Neuroscience Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-25-165862), on July 28, 2025, and is solely responsible for the information contained therein.